Table 2.
Sham | Treatment (alpha-lipoic acid) | Control | |||||||
---|---|---|---|---|---|---|---|---|---|
Weeks | 4 | 8 | 12 | 4 | 8 | 12 | 4 | 8 | 12 |
N | 8024±404 | 8379 ± 446 | 8124 ± 385 | 2511 ± 183 | 2733±231 | 3255± 189 | 1378 ± 176† | 2673 ± 215 | 3024 ± 198 |
D | 12.01±0.01 | 11.93±0.17 | 12.06±0.23 | 7.34± 0.49 | 9.88± 0.33 | 10.54± 0.42 | 2.83 ± 0.18† | 4.51± 0.24† | 4.86 ± 0.19† |
d | 7.03 ± 0.02 | 6.97 ± 0.39 | 7.06 ± 0.46 | 3.44 ± 0.39 | 5.37± 0.27 | 6.22 ± 0.18 | 2.12 ± 0.22† | 3.74± 0.23† | 3.77±0.21† |
T | 2.56 ± 0.01 | 2.48 ± 0.02 | 2.53 ± 0.01 | 2.14± 0.32 | 2.21 ± 0.26 | 2.29 ± 0.29 | 0.41± 0.02† | 0.43 ± 0.03† | 0.63 ± 0.03† |
N: number of fibers, D: diameter of fibers (µm), d: diameter of axon (µm), T: thickness of myelin sheath (µm).
results were significantly different at P-value <0.05